Process and analytical development of bitox
Ended Awarded Last action
- Contract number
- 75N95021F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,057,916
Award facts
- Opportunity
-
- 75N95021R00055 Solicitation number
- Contract value 100% obligated
- $1,057,916.06 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$149,724 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$715,552 | |
| Supplemental Agreement for work within scope | $715,552 | |
| Original award | $1,207,640 |
About this award
The National Center for Advancing Translational Sciences issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 24, 2021, with a ceiling value of $1,057,916.06 for process and analytical development of Bitox under the CRO Support for NCATS Drug Substance Development and Manufacture IDIQ. Place of performance is Rockville, MD. Ultimate completion date is September 26, 2026.
The order carries Cost Plus Fixed Fee pricing. Service Contract Inventory reporting shows actual government-invoiced labor trending upward: FY2021 through FY2025 invoiced $2 thousand through $360 thousand respectively, with labor footprint reaching 0.4 FTEs in FY2025. Derived hourly rates ranged from $232.32 to $1,752.82 across reported fiscal years. Advanced Bioscience Laboratories self-performed all reported hours in FY2025 with no subcontractor engagement.
Quick answers
Who was awarded contract 75N95021F00001?
75N95021F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2021.
How much is contract 75N95021F00001 worth?
The government has obligated $1,057,916 on 75N95021F00001.
Which agency awarded contract 75N95021F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95021F00001 an order under another contract?
Yes. 75N95021F00001 is a delivery order under HHSN271201700010I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.
Was contract 75N95021F00001 competed?
The extent of competition for 75N95021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award